Sign In
Buy DYAI
$1.05
-0.0200 (-1.87%)
At Close: Jul 31, 2026
Dyadic Reports 2019 Year End Results and Recent Developments
08:00pm, Monday, 30'th Mar 2020
New research license agreement with WuXi Biologics, a leading global CDMO Two new fully funded collaborations and one expanded collaboration signed in 2020, including the t hird fully funded collabora
Dyadic International, Inc. to Host Earnings Call
07:00pm, Monday, 30'th Mar 2020
NEW YORK, NY / ACCESSWIRE / March 30, 2020 / Dyadic International, Inc. (NASDAQ:DYAI) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 30, 2020
Dyadic Announces Nonexclusive Research License with WuXi Biologics
01:00pm, Monday, 30'th Mar 2020
JUPITER, FL / ACCESSWIRE / March 30, 2020 / Dyadic International, Inc. ("Dyadic" or the "Company") (DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 g
The Week Ahead In Biotech: Clinical Readouts, COVID-19 News Flow In Focus Amid Continuing Uncertainty
04:10pm, Sunday, 29'th Mar 2020
After starting the week ended March 28 on the backfoot, biotech stocks recovered through the week. Activity in the space remained light, although coronavirus (COVID-19) news flow continued to dominate
Dyadic International, Inc. to Present at the New York City based Investor Summit on March 25th-26th
01:00pm, Thursday, 19'th Mar 2020
NEW YORK, NY / ACCESSWIRE / March 19, 2020 / Dyadic International, Inc. (Nasdaq: DYAI) Dyadic's Chief Financial Officer Ping Rawson will be presenting at this year's New York City based Investor Summi
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
12:00am, Thursday, 19'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 18)
Biomerica, Inc. (NASDAQ...
Dyadic Presents New Business Opportunities to Address COVID-19, Influenza and Continued Scientific and Business Development Progress
08:15pm, Wednesday, 18'th Mar 2020
JUPITER, FL / ACCESSWIRE / March 18, 2020 / Dyadic International, Inc. ("Dyadic" or the "Company") (DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 g
Dyadic to Report Year End 2019 Financial Results on Monday, March 30, 2020
12:00pm, Monday, 16'th Mar 2020
JUPITER, FL / ACCESSWIRE / March 16, 2020 / Dyadic International, Inc. ("Dyadic") (DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 expression system
Comparing BIO-TECHNE (NASDAQ:TECH) & Dyadic International (NASDAQ:DYAI)
05:36am, Sunday, 15'th Mar 2020
BIO-TECHNE (NASDAQ:TECH) and Dyadic International (NASDAQ:DYAI) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst
Neurocrine Biosciences (NASDAQ:NBIX) & Dyadic International (NASDAQ:DYAI) Head-To-Head Comparison
05:34am, Friday, 13'th Mar 2020
Neurocrine Biosciences (NASDAQ:NBIX) and Dyadic International (NASDAQ:DYAI) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of
Orchard Therapeutics (NASDAQ:ORTX) versus Dyadic International (NASDAQ:DYAI) Critical Contrast
06:06am, Friday, 06'th Mar 2020
Orchard Therapeutics (NASDAQ:ORTX) and Dyadic International (NASDAQ:DYAI) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength
Dyadic International's (NASDAQ:DYAI) Wonderful 462% Share Price Increase Shows How Capitalism Can Build Wealth
01:19pm, Monday, 02'nd Mar 2020
Buying shares in the best businesses can build meaningful wealth for you and your family. While the best companies are...
Coronavirus update: Trump taps Pence to lead coronavirus response; first case in CA with no travel link
08:19pm, Wednesday, 26'th Feb 2020
Europe’s attempts to contain its escalating coronavirus outbreak appeared to be faltering, as Germany became the latest country to warn that it was on the verge of an epidemic.
Dyadic and The Israel Institute for Biological Research (IIBR) Expand Collaboration to Combat Emerging Diseases
03:15pm, Tuesday, 25'th Feb 2020
NES-ZIONA, ISRAEL and JUPITER, FL / ACCESSWIRE / February 25, 2020 / Dyadic International, Inc. (''Dyadic'') (DYAI), a global biotechnology company announced today that they are joining the global fig
Dyadic Announces New Milestone as G2 Human Like Glycosylation Reached
01:30pm, Monday, 24'th Feb 2020
JUPITER, FL / ACCESSWIRE / February 24, 2020 / Dyadic International, Inc. ("Dyadic") (DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression
